In this issue:
Progress in the treatment of uveal melanoma
Second opinions in histological diagnoses of melanoma
Comparing patients with multiple and single primary melanomas
Combination ipilimumab plus nivolumab in mucosal melanoma
Cost-effectiveness of adjuvant pembrolizumab
ICI + short-term intermittent targeted treatment
Autophagy and melanoma prognosis
Genetics to identify patients with severe AEs
Radiation necrosis in combination with SRS and ICI
Metformin in adjuvant anti-PD1 EORTIC1325 study
Please login below to download this issue (PDF)